WHO ICTRP trial
Combined expression and significance study of PRL-3, MMP9 in circulating tumor…
ChiCTR-RDD-16007819 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-RDD-16007819 |
|---|---|
| Public title | Combined expression and significance study of PRL-3, MMP9 in circulating tumor ceils of colorectal cancer |
| Scientific title | Combined expression and significance study of PRL-3, MMP9 in circulating tumor ceils of colorectal cancer |
| Primary sponsor | Affiliated hospital of Guangdong Medicine College |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Relative factors research |
| Phase | Diagnostic New Technique Clincal Study |
| Countries | China |
| Conditions | oncology |
| Interventions | 3:none |
| Registration date | Jan 24, 2016 |
| Target size | 3:40 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: